Key facts
- This page summarizes Sarborg Ltd's Form 3 filing for CONDUIT PHARMACEUTICALS INC. (CDT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 May 2025, 17:35.
Sarborg Ltd - 31 Mar 2025 Form 3 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CDT
- Reported as of
- 31 Mar 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Mark Taylor, Executive Director of Sarborg Ltd
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Sarborg Ltd filed Form 3 for CONDUIT PHARMACEUTICALS INC. (CDT) on 07 May 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002066774
Primary reporting owner
Sarborg Ltd
- Relationship
- 10%+ Owner
- Address
- WILLOW HOUSE, CRICKET SQUARE, GRAND CAYMAN, CAYMAN ISLANDS
- Signature
- /s/ Mark Taylor, Executive Director of Sarborg Ltd
- Signature date
- 07 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,853,933
- Date
- 31 Mar 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.